NASDAQ:ATHN - athenahealth Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$153.19 -0.26 (-0.17 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$153.19
Today's Range$152.6150 - $154.3875
52-Week Range$111.61 - $158.66
Volume166,700 shs
Average Volume827,226 shs
Market Capitalization$6.20 billion
P/E Ratio97.57
Dividend YieldN/A

About athenahealth (NASDAQ:ATHN)

athenahealth logoathenahealth, Inc., together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services. The company also provides athenahealth Population Health, a cloud-based population health service; and Epocrates services that include clinical information and decision support services in the areas of drug and disease information, medical calculator and tools, clinical guidelines, clinical messaging, and market research. In addition, it offers athenahealth Health Plan data exchange facilitates to exchange the data between providers and health plans for the healthcare operations of clients; athenaOne Analytics that includes an analytics and dashboard application, as well as provides visibility into the financial and operational health of an organization; and pre-certification processing and referral processing services. The company serves healthcare providers, medical groups, and health systems through its direct sales force and channel partners in the United States and internationally. athenahealth, Inc. was formerly known as, Inc. and changed its name to athenahealth, Inc. in November 2000. The company was founded in 1997 and is headquartered in Watertown, Massachusetts.

Receive ATHN News and Ratings via Email

Sign-up to receive the latest news and ratings for ATHN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryHealth Care Technology


Debt-to-Equity Ratio0.25
Current Ratio2.71
Quick Ratio2.71


Trailing P/E Ratio97.57
Forward P/E Ratio52.46
P/E Growth2.85

Sales & Book Value

Annual Sales$1.22 billion
Price / Sales5.07
Cash Flow$5.2697 per share
Price / Cash29.07
Book Value$24.09 per share
Price / Book6.36


EPS (Most Recent Fiscal Year)$1.57
Net Income$53.10 million
Net Margins6.77%
Return on Equity13.01%
Return on Assets7.91%


Outstanding Shares40,410,000

athenahealth (NASDAQ:ATHN) Frequently Asked Questions

What is athenahealth's stock symbol?

athenahealth trades on the NASDAQ under the ticker symbol "ATHN."

How were athenahealth's earnings last quarter?

athenahealth (NASDAQ:ATHN) posted its earnings results on Thursday, April, 26th. The health services provider reported $1.25 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.72 by $0.53. The health services provider earned $329.40 million during the quarter, compared to analysts' expectations of $318.13 million. athenahealth had a net margin of 6.77% and a return on equity of 13.01%. The company's quarterly revenue was up 15.4% compared to the same quarter last year. During the same period last year, the company posted $0.32 EPS. View athenahealth's Earnings History.

When is athenahealth's next earnings date?

athenahealth is scheduled to release their next quarterly earnings announcement on Wednesday, July, 18th 2018. View Earnings Estimates for athenahealth.

What price target have analysts set for ATHN?

25 brokerages have issued 1-year price objectives for athenahealth's shares. Their forecasts range from $125.00 to $184.00. On average, they anticipate athenahealth's stock price to reach $152.6364 in the next twelve months. View Analyst Ratings for athenahealth.

What are Wall Street analysts saying about athenahealth stock?

Here are some recent quotes from research analysts about athenahealth stock:
  • 1. Cantor Fitzgerald analysts commented, "Technology strategy evolving. After its analyst meeting in February, our sense was that the company was trying to add more capabilities to its platform in order to create more value for existing clients. It appears as though the strategy is far more complicated as the company is attempting to move from a monolithic platform" to provide micro-services". In essence, the company will attempt to unbundle its services and allow providers to use these services on an incremental basis. This development work has been underway for some time now. The company was reluctant to commit to when the micro-services" will be commercially available. But the transition is an important component of the company’s future growth strategy." (5/14/2018)
  • 2. Canaccord Genuity analysts commented, "We remain neutral on the stock until we get a better understanding of the restructuring initiatives, financial predictability, and the go-forward growth strategy. Pre-call takeaways: Upside to revenue, with significant bottom-line beat. Rev. of $329.2M (+14.2%) beat our est. $324.8M and cons. $320.0M, and came in at the high end of implied guidance range $309-$329M. Beats on adjusted gross margin and all expense line items enabled the company to post non-GAAP op. inc. of $77.6M (+82.6%), far surpassing us and cons. both near ~$45M and implied guidance of $38-53M. Adj-EPS of $1.11 also beat our est. $0.65 and cons. $0.63." (2/1/2018)

Who are some of athenahealth's key competitors?

Who are athenahealth's key executives?

athenahealth's management team includes the folowing people:
  • Mr. Jonathan J. Bush, Pres, CEO & Director (Age 49)
  • Mr. Timothy John O'Brien, Sr. VP of Commercial Operations & Chief Marketing Officer (Age 42)
  • Dr. Stephen N. Kahane M.D., M.S, Exec. Director of Client Organization (Age 60)
  • Mr. Marc A. Levine, Exec. VP, CFO, Treasurer & Principal Accounting Officer (Age 58)
  • Mr. Prakash Khot, Exec. VP & CTO (Age 48)

Has athenahealth been receiving favorable news coverage?

Media headlines about ATHN stock have trended somewhat positive recently, according to Accern. Accern rates the sentiment of news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. athenahealth earned a media sentiment score of 0.11 on Accern's scale. They also gave media headlines about the health services provider an impact score of 45.04 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Who are athenahealth's major shareholders?

athenahealth's stock is owned by a variety of of retail and institutional investors. Top institutional investors include FMR LLC (6.20%), BlackRock Inc. (4.15%), ELLIOTT ASSOCIATES, L.P. (1.40%), Sumitomo Mitsui Trust Holdings Inc. (1.39%), Allianz Asset Management GmbH (0.99%) and Allianz Asset Management GmbH (0.99%). Company insiders that own athenahealth stock include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, David Eric Robinson, Ed Park, Jeffrey R Immelt, John A Kane, Jonathan Bush, Jonathan D Porter, Karl Stubelis and Timothy John O'brien. View Institutional Ownership Trends for athenahealth.

Which major investors are selling athenahealth stock?

ATHN stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, Allianz Asset Management GmbH, Toronto Dominion Bank, Zurcher Kantonalbank Zurich Cantonalbank, Sei Investments Co., Hsbc Holdings PLC, A.R.T. Advisors LLC and Envestnet Asset Management Inc.. Company insiders that have sold athenahealth company stock in the last year include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, David Eric Robinson, Jonathan Bush, Jonathan D Porter, Karl Stubelis and Timothy John O'brien. View Insider Buying and Selling for athenahealth.

Which major investors are buying athenahealth stock?

ATHN stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, Summit Trail Advisors LLC, Natixis, Victory Capital Management Inc., Federated Investors Inc. PA, Wells Fargo & Company MN, Prudential Financial Inc. and Kornitzer Capital Management Inc. KS. View Insider Buying and Selling for athenahealth.

How do I buy shares of athenahealth?

Shares of ATHN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is athenahealth's stock price today?

One share of ATHN stock can currently be purchased for approximately $153.19.

How big of a company is athenahealth?

athenahealth has a market capitalization of $6.20 billion and generates $1.22 billion in revenue each year. The health services provider earns $53.10 million in net income (profit) each year or $1.57 on an earnings per share basis. athenahealth employs 5,156 workers across the globe.

How can I contact athenahealth?

athenahealth's mailing address is 311 ARSENAL STREET, WATERTOWN MA, 02472. The health services provider can be reached via phone at 617-402-1000 or via email at [email protected]

MarketBeat Community Rating for athenahealth (ATHN)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  543 (Vote Outperform)
Underperform Votes:  608 (Vote Underperform)
Total Votes:  1,151
MarketBeat's community ratings are surveys of what our community members think about athenahealth and other stocks. Vote "Outperform" if you believe ATHN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATHN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

athenahealth (NASDAQ:ATHN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
25 Wall Street analysts have issued ratings and price targets for athenahealth in the last 12 months. Their average twelve-month price target is $152.6364, suggesting that the stock has a possible downside of 0.36%. The high price target for ATHN is $184.00 and the low price target for ATHN is $125.00. There are currently 17 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.322.242.252.40
Ratings Breakdown: 0 Sell Rating(s)
17 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
17 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
16 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
13 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $152.6364$145.3478$144.2273$143.2174
Price Target Upside: 0.36% downside1.46% upside2.12% upside16.58% upside

athenahealth (NASDAQ:ATHN) Consensus Price Target History

Price Target History for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ:ATHN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/22/2018Deutsche BankBoost Price TargetHold ➝ Hold$160.00 ➝ $170.00LowView Rating Details
5/17/2018Jefferies GroupSet Price TargetHold$160.00LowView Rating Details
5/17/2018Royal Bank of CanadaReiterated RatingHold$160.00LowView Rating Details
5/15/2018Berenberg BankDowngradeBuy ➝ Hold$143.00 ➝ $163.00LowView Rating Details
5/14/2018Cantor FitzgeraldReiterated RatingHold$140.00LowView Rating Details
5/8/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$150.00LowView Rating Details
5/8/2018Leerink SwannSet Price TargetHold$150.00HighView Rating Details
5/8/2018Evercore ISIUpgradeIn-Line ➝ Outperform$140.00HighView Rating Details
4/30/2018CitigroupLower Price TargetNeutral ➝ Neutral$148.00 ➝ $140.00HighView Rating Details
4/24/2018JPMorgan Chase & Co.Initiated CoverageNeutral ➝ Neutral$148.00 ➝ $159.00LowView Rating Details
2/27/2018Bank of AmericaInitiated CoverageNeutral ➝ Neutral$147.00LowView Rating Details
2/16/2018Piper Jaffray CompaniesReiterated RatingBuy$160.00LowView Rating Details
2/5/2018SunTrust BanksBoost Price TargetBuy$180.00HighView Rating Details
2/1/2018Canaccord GenuityBoost Price TargetHold ➝ Hold$123.00 ➝ $137.00HighView Rating Details
1/12/2018KeyCorpReiterated RatingBuy$152.00HighView Rating Details
10/23/2017Wells Fargo & CoLower Price TargetOutperform$190.00 ➝ $155.00N/AView Rating Details
10/23/2017First AnalysisUpgradeUnderweight ➝ Equal Weight$125.00 ➝ $127.00N/AView Rating Details
10/20/2017OppenheimerReiterated RatingBuy$184.00N/AView Rating Details
8/2/2017Morgan StanleyReiterated RatingEqual Weight$108.00 ➝ $125.00LowView Rating Details
7/31/2017CowenDowngradeOutperform ➝ Market Perform$127.00 ➝ $133.00MediumView Rating Details
7/24/2017UBSReiterated RatingBuy ➝ Positive$157.00 ➝ $175.00LowView Rating Details
7/21/2017William BlairReiterated RatingMarket PerformMediumView Rating Details
7/7/2017Dougherty & CoDowngradeBuy ➝ NeutralHighView Rating Details
7/7/2017ArgusInitiated CoverageHoldHighView Rating Details
6/16/2017Stifel NicolausReiterated RatingHold$106.00 ➝ $151.00LowView Rating Details
5/1/2017BarclaysSet Price TargetUnderweight$97.00 ➝ $88.00MediumView Rating Details
1/4/2017Pacific CrestUpgradeOverweight$140.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMarket Perform$145.00 ➝ $140.00N/AView Rating Details
(Data available from 5/26/2016 forward)


athenahealth (NASDAQ:ATHN) Earnings History and Estimates Chart

Earnings by Quarter for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ:ATHN) Earnings Estimates

2018 EPS Consensus Estimate: $1.41
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.22$0.22$0.22
Q2 20181$0.33$0.33$0.33
Q3 20181$0.34$0.34$0.34
Q4 20181$0.52$0.52$0.52

athenahealth (NASDAQ ATHN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/18/2018$0.95N/AView Earnings Details
4/26/2018Q1 2018$0.72$1.25$318.13 million$329.40 millionViewN/AView Earnings Details
2/1/2018Q4 2017$0.63$1.11$319.64 million$329.20 millionViewListenView Earnings Details
10/19/2017Q3 2017$0.50$0.56$310.52 million$304.60 millionViewN/AView Earnings Details
7/20/2017Q2 2017$0.39$0.51$298.68 million$301.10 millionViewN/AView Earnings Details
4/27/2017Q1 2017$0.11$0.10$296.49 million$285.40 millionViewN/AView Earnings Details
2/2/2017Q4 2016$0.5080$0.62$303.72 million$288.20 millionViewListenView Earnings Details
10/20/2016Q3$0.47$0.60$280.17 million$276.67 millionViewListenView Earnings Details
7/21/2016Q2$0.42$0.34$274.07 million$261.90 millionViewListenView Earnings Details
4/28/2016Q1$0.26$0.34$248.49 million$256.15 millionViewListenView Earnings Details
2/4/2016Q415$0.41$0.45$257.68 million$257.50 millionViewN/AView Earnings Details
10/22/2015Q315$0.26$0.36$233.03 million$236.10 millionViewListenView Earnings Details
7/23/2015Q215$0.25$0.32$227.08 million$224.70 millionViewListenView Earnings Details
4/30/2015Q115($0.10)$0.24$205.24 million$206.40 millionViewListenView Earnings Details
2/5/2015Q414$0.39$0.58$207.99 million$213.20 millionViewN/AView Earnings Details
10/16/2014Q314$0.27$0.27$190.40 million$190.40 millionViewListenView Earnings Details
7/17/2014Q214$0.22$0.32$182.14 million$185.90 millionViewN/AView Earnings Details
4/17/2014Q114($0.01)$0.12$170.03 million$163.00 millionViewListenView Earnings Details
2/6/2014Q413$0.45$0.57$168.39 million$171.60 millionViewN/AView Earnings Details
10/17/2013Q313$0.31$0.29$154.80 million$151.50 millionViewN/AView Earnings Details
7/18/2013Q2 2013$0.22($0.08)$148.24 million$149.30 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.23$0.38$121.05 million$125.60 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.28$0.29$116.97 million$116.30 millionViewListenView Earnings Details
10/18/2012$0.26$0.30ViewN/AView Earnings Details
7/19/2012$0.23$0.24ViewN/AView Earnings Details
4/26/2012$0.17$0.17ViewN/AView Earnings Details
2/15/2012$0.23$0.26ViewN/AView Earnings Details
10/20/2011$0.20$0.24ViewN/AView Earnings Details
7/21/2011$0.19$0.22ViewN/AView Earnings Details
4/28/2011$0.13$0.17ViewN/AView Earnings Details
2/17/2011$0.20$0.28ViewN/AView Earnings Details
10/21/2010Q3 2010$0.08$0.11ViewN/AView Earnings Details
7/22/2010Q2 2010$0.06$0.04ViewN/AView Earnings Details
4/29/2010Q1 2010$0.10$0.02ViewN/AView Earnings Details
3/15/2010Q4 2009$0.12$0.12ViewN/AView Earnings Details
10/29/2009Q3 2009$0.10$0.08ViewN/AView Earnings Details
8/5/2009Q2 2009$0.09$0.09ViewN/AView Earnings Details
4/30/2009Q1 2009$0.10$0.07ViewN/AView Earnings Details
2/26/2009Q4 2008$0.13$0.11ViewN/AView Earnings Details
11/6/2008Q3 2008$0.09$0.11ViewN/AView Earnings Details
8/4/2008Q2 2008$0.07$0.08ViewN/AView Earnings Details
5/6/2008Q1 2008$0.06$0.05ViewN/AView Earnings Details
3/5/2008Q4 2007$0.06$0.06ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


athenahealth (NASDAQ:ATHN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

athenahealth (NASDAQ ATHN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.90%
Insider Trading History for athenahealth (NASDAQ:ATHN)
Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ ATHN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/16/2018Daniel P HaleyInsiderSell1,107$149.40$165,385.8012,383View SEC Filing  
5/7/2018Jonathan BushCEOSell25,000$155.00$3,875,000.00View SEC Filing  
5/7/2018Jonathan D. PorterSVPSell422$153.30$64,692.60View SEC Filing  
5/1/2018Jonathan BushCEOSell5,000$124.01$620,050.00340,106View SEC Filing  
4/26/2018Jonathan D. PorterSVPSell150$143.41$21,511.50View SEC Filing  
4/2/2018Jonathan BushCEOSell5,000$140.47$702,350.00340,106View SEC Filing  
3/26/2018Jonathan D. PorterSVPSell150$141.00$21,150.00View SEC Filing  
3/2/2018Bradford Kyle ArmbresterSVPSell2,235$138.70$309,994.5010,146View SEC Filing  
3/2/2018Timothy John O'brienCMOSell3,064$137.27$420,595.2811,320View SEC Filing  
3/1/2018Daniel P HaleyInsiderSell1,153$136.83$157,764.9912,436View SEC Filing  
3/1/2018Jonathan BushCEOSell250$139.27$34,817.50321,533View SEC Filing  
2/27/2018Jeffrey R. ImmeltDirectorBuy3,600$141.04$507,744.00View SEC Filing  
2/27/2018Jonathan BushCEOSell4,750$141.11$670,272.50320,557View SEC Filing  
2/26/2018Jonathan D. PorterSVPSell150$139.87$20,980.50View SEC Filing  
2/20/2018Jeffrey R ImmeltDirectorBuy7,200$138.44$996,768.00678View SEC Filing  
2/5/2018Jonathan BushCEOSell25,000$145.00$3,625,000.00View SEC Filing  
2/2/2018Brandon H HullDirectorSell653$133.00$86,849.005,230View SEC Filing  
2/1/2018Jonathan BushCEOSell5,000$122.69$613,450.00320,807View SEC Filing  
1/26/2018Jonathan D. PorterSVPSell150$128.26$19,239.00View SEC Filing  
1/2/2018David Eric RobinsonDirectorSell5,000$133.94$669,700.008,596View SEC Filing  
12/29/2017Jonathan D PorterSVPSell150$134.52$20,178.00View SEC Filing  
12/29/2017Jonathan D. PorterSVPSell150$134.52$20,178.00View SEC Filing  
12/26/2017Amy AbernethyDirectorSell500$134.18$67,090.004,045View SEC Filing  
12/26/2017Amy AbernethyDirectorSell500$134.18$67,090.004,045View SEC Filing  
12/26/2017Jonathan BushCEOSell30,000$134.80$4,044,000.00320,807View SEC Filing  
12/26/2017Jonathan BushCEOSell30,000$134.80$4,044,000.00320,807View SEC Filing  
12/1/2017Brandon H. HullDirectorSell800$132.97$106,376.00View SEC Filing  
11/20/2017Brandon H. HullDirectorSell800$130.00$104,000.00View SEC Filing  
10/27/2017Bradford Kyle ArmbresterSVPSell1,000$128.56$128,560.00View SEC Filing  
10/20/2017Brandon H. HullDirectorSell800$130.00$104,000.00View SEC Filing  
10/2/2017Daniel P HaleyInsiderSell1,583$124.56$197,178.4813,408View SEC Filing  
10/2/2017Jonathan BushCEOSell4,000$124.17$496,680.00319,807View SEC Filing  
9/15/2017Jonathan D. PorterSVPSell300$130.38$39,114.00View SEC Filing  
9/1/2017Brandon H. HullDirectorSell800$140.95$112,760.00View SEC Filing  
9/1/2017Jonathan BushCEOSell4,000$139.77$559,080.00319,807View SEC Filing  
8/15/2017Jonathan D. PorterSVPSell300$142.88$42,864.00View SEC Filing  
8/1/2017Brandon H. HullDirectorSell800$140.01$112,008.00View SEC Filing  
8/1/2017Jonathan BushCEOSell4,000$143.31$573,240.00319,807View SEC Filing  
7/21/2017Jonathan D. PorterSVPSell422$154.00$64,988.00View SEC Filing  
7/17/2017Jonathan D. PorterSVPSell300$143.13$42,939.00View SEC Filing  
7/3/2017Brandon H. HullDirectorSell800$140.81$112,648.00View SEC Filing  
7/3/2017Jonathan BushCEOSell4,000$140.52$562,080.00319,807View SEC Filing  
6/15/2017Jonathan D. PorterSVPSell300$142.27$42,681.00View SEC Filing  
6/5/2017Karl StubelisCFOSell3,952$138.98$549,248.9621,810View SEC Filing  
5/18/2017Bradford Kyle ArmbresterSVPSell2,431$130.00$316,030.00View SEC Filing  
5/18/2017Brandon H. HullDirectorSell1,600$130.00$208,000.00View SEC Filing  
5/18/2017Jonathan BushCEOSell4,000$125.85$503,400.00319,807View SEC Filing  
5/15/2017Jonathan D. PorterSVPSell300$109.48$32,844.00View SEC Filing  
4/25/2017Jonathan BushCEOSell8,000$120.00$960,000.00319,807View SEC Filing  
1/27/2017John A KaneDirectorSell2,875$123.11$353,941.258,958View SEC Filing  
1/12/2017Jonathan BushCEOSell4,000$120.00$480,000.00312,109View SEC Filing  
12/15/2016Amy AbernethyDirectorSell1,000$117.15$117,150.002,649View SEC Filing  
12/15/2016Ed ParkCOOSell2,500$117.15$292,875.0013,219View SEC Filing  
12/15/2016Jonathan BushCEOSell8,000$120.00$960,000.00312,109View SEC Filing  
12/1/2016Ed ParkCOOSell1,500$94.60$141,900.0010,719View SEC Filing  
10/27/2016John A. KaneDirectorSell5,750$122.63$705,122.50View SEC Filing  
10/10/2016Bradford Kyle ArmbresterSVPSell2,545$130.00$330,850.00View SEC Filing  
10/10/2016Brandon H HullDirectorSell2,400$130.00$312,000.003,987View SEC Filing  
10/3/2016Daniel P HaleySVPSell2,109$124.43$262,422.873,195View SEC Filing  
10/3/2016Jonathan BushCEOSell4,000$124.34$497,360.00312,109View SEC Filing  
9/7/2016Karl StubelisVPSell928$123.36$114,478.081,375View SEC Filing  
8/15/2016Ed ParkCOOSell4,000$124.20$496,800.0020,719View SEC Filing  
8/1/2016Jonathan BushCEOSell4,000$128.19$512,760.00312,109View SEC Filing  
7/27/2016John A KaneDirectorSell2,875$128.81$370,328.7510,708View SEC Filing  
7/6/2016Ed ParkCOOSell1,500$136.85$205,275.0018,819View SEC Filing  
7/1/2016Brandon H HullDirectorSell800$137.48$109,984.006,387View SEC Filing  
7/1/2016Jonathan BushCEOSell4,000$138.21$552,840.00312,109View SEC Filing  
6/2/2016Brandon H HullDirectorSell800$130.00$104,000.007,187View SEC Filing  
6/1/2016Ed ParkCOOSell1,500$125.82$188,730.0019,819View SEC Filing  
6/1/2016Jonathan BushCEOSell4,000$125.97$503,880.00312,109View SEC Filing  
5/4/2016Ed ParkCOOSell1,500$127.81$191,715.0021,819View SEC Filing  
5/2/2016Brandon H HullDirectorSell800$132.74$106,192.007,987View SEC Filing  
5/2/2016Jonathan BushCEOSell4,000$132.09$528,360.00312,109View SEC Filing  
5/2/2016Kristi Ann MatusEVPSell415$133.27$55,307.0534,116View SEC Filing  
4/25/2016Karl StubelisVPSell547$138.64$75,836.08View SEC Filing  
4/6/2016Ed ParkCOOSell1,500$139.15$208,725.0022,919View SEC Filing  
4/1/2016Brandon H HullDirectorSell800$137.72$110,176.008,787View SEC Filing  
4/1/2016Jonathan BushCEOSell4,000$138.44$553,760.00307,408View SEC Filing  
4/1/2016Kristi Ann MatusEVPSell415$138.61$57,523.1534,531View SEC Filing  
3/3/2016Bradford Kyle ArmbresterSVPSell1,369$132.04$180,762.76View SEC Filing  
3/1/2016Brandon H HullDirectorSell1,600$130.00$208,000.008,687View SEC Filing  
3/1/2016Daniel P HaleySVPSell1,279$130.64$167,088.56365View SEC Filing  
3/1/2016Ed ParkCOOSell1,500$131.66$197,490.0026,270View SEC Filing  
3/1/2016Jonathan BushCEOSell4,000$129.61$518,440.00312,109View SEC Filing  
3/1/2016Kristi Ann MatusEVPSell415$129.53$53,754.9533,357View SEC Filing  
3/1/2016Timothy John O'brienCMOSell846$132.25$111,883.5062View SEC Filing  
2/16/2016Bradford Kyle ArmbresterSVPSell1,657$127.11$210,621.272,500View SEC Filing  
2/16/2016Timothy John O'brienCMOSell816$127.08$103,697.281,250View SEC Filing  
2/3/2016Ed ParkCOOSell1,500$140.61$210,915.0027,433View SEC Filing  
2/1/2016Jonathan BushCEOSell4,000$140.14$560,560.00308,109View SEC Filing  
2/1/2016Kristi Ann MatusEVPSell415$141.08$58,548.2033,772View SEC Filing  
1/27/2016John A. KaneDirectorSell2,875$140.81$404,828.756,133View SEC Filing  
1/6/2016Ed ParkCOOSell1,500$161.89$242,835.0028,933View SEC Filing  
1/4/2016Jonathan BushCEOSell4,000$156.79$627,160.00308,109View SEC Filing  
1/4/2016Kristi Ann MatusEVPSell415$159.06$66,009.9034,187View SEC Filing  
12/2/2015Ed ParkCOOSell1,500$166.81$250,215.0030,433View SEC Filing  
11/20/2015Stephen N KahaneEVPSell1,280$157.80$201,984.0017,829View SEC Filing  
11/6/2015Stephen N KahaneEVPSell5,000$159.51$797,550.0019,109View SEC Filing  
11/4/2015Ed ParkCOOSell1,500$162.32$243,480.0031,933View SEC Filing  
11/3/2015Jonathan BushCEOSell14,750$156.50$2,308,375.00311,234View SEC Filing  
10/27/2015John A. KaneDirectorSell2,875$150.44$432,515.006,133View SEC Filing  
10/23/2015Jonathan BushCEOSell20,000$157.50$3,150,000.00311,234View SEC Filing  
10/23/2015Robert CosinukeCMOSell1,211$159.02$192,573.2240,322View SEC Filing  
10/23/2015Stephen N KahaneEVPSell5,000$150.50$752,500.0024,109View SEC Filing  
10/20/2015Stephen N KahaneEVPSell2,000$132.88$265,760.0029,109View SEC Filing  
10/7/2015Ed ParkCOOSell1,500$134.23$201,345.0033,433View SEC Filing  
10/2/2015Jonathan BushCEOSell1,000$130.74$130,740.00311,234View SEC Filing  
9/15/2015Stephen N KahaneEVPSell2,000$135.77$271,540.0031,031View SEC Filing  
9/2/2015Ed ParkCOOSell1,500$129.64$194,460.0034,933View SEC Filing  
9/2/2015Jonathan BushCEOSell1,000$131.09$131,090.00311,234View SEC Filing  
8/18/2015Stephen N KahaneEVPSell2,000$141.49$282,980.00View SEC Filing  
7/24/2015David Eric RobinsonDirectorSell10,000$130.00$1,300,000.00View SEC Filing  
7/21/2015Stephen N KahaneEVPSell2,000$117.32$234,640.00View SEC Filing  
7/2/2015Jonathan BushCEOSell1,000$114.17$114,170.00View SEC Filing  
6/2/2015Jonathan BushCEOSell1,000$115.32$115,320.00View SEC Filing  
4/27/2015John A KaneDirectorSell2,875$125.35$360,381.25View SEC Filing  
4/14/2015Karl StubelisVPSell1,115$126.28$140,802.20View SEC Filing  
4/2/2015Jonathan BushCEOSell1,000$118.77$118,770.00View SEC Filing  
3/10/2015James L MannDirectorSell13,106$121.27$1,589,364.62View SEC Filing  
3/3/2015Robert CosinukeCMOSell6,000$128.15$768,900.00View SEC Filing  
2/24/2015Jonathan BushCEOSell2,499$130.23$325,444.77View SEC Filing  
2/18/2015Jonathan BushCEOSell2,498$132.04$329,835.92View SEC Filing  
2/10/2015Jonathan BushCEOSell7,495$135.82$1,017,970.90View SEC Filing  
2/5/2015David Eric RobinsonDirectorSell25,000$143.17$3,579,250.00View SEC Filing  
2/3/2015Robert CosinukeCMOSell6,000$139.06$834,360.00View SEC Filing  
1/5/2015David Eric RobinsonDirectorSell25,000$145.14$3,628,500.00View SEC Filing  
1/5/2015Robert CosinukeCMOSell6,000$145.18$871,080.00View SEC Filing  
12/22/2014Robert CosinukeCMOSell6,000$139.32$835,920.00View SEC Filing  
12/2/2014Jonathan BushCEOSell1,000$116.55$116,550.00View SEC Filing  
10/10/2014Robert CosinukeCMOSell3,000$123.78$371,340.00View SEC Filing  
10/2/2014Jonathan BushCEOSell1,000$128.41$128,410.00View SEC Filing  
9/10/2014Robert CosinukeCMOSell6,000$138.08$828,480.00View SEC Filing  
8/11/2014Robert CosinukeCMOSell6,000$129.43$776,580.00View SEC Filing  
8/4/2014Jonathan BushCEOSell1,000$121.58$121,580.00View SEC Filing  
7/10/2014Robert CosinukeCMOSell6,000$120.10$720,600.00View SEC Filing  
7/2/2014Jonathan BushCEOSell1,000$129.45$129,450.00View SEC Filing  
7/1/2014Stephen N KahaneInsiderSell5,000$127.60$638,000.00View SEC Filing  
6/12/2014David Eric RobinsonDirectorSell30,000$124.12$3,723,600.00View SEC Filing  
6/10/2014Robert CosinukeCMOSell6,000$125.07$750,420.00View SEC Filing  
6/2/2014Jonathan BushCEOSell1,000$125.82$125,820.00View SEC Filing  
6/2/2014Stephen N KahaneInsiderSell5,000$126.42$632,100.00View SEC Filing  
5/2/2014Jonathan BushCEOSell1,000$123.21$123,210.00311,234View SEC Filing  
5/1/2014Stephen KahaneInsiderSell5,000$121.96$609,800.0064,285View SEC Filing  
4/16/2014Stephen KahaneInsiderSell10,000$143.96$1,439,600.0069,285View SEC Filing  
4/14/2014David Eric RobinsonDirectorSell60,000$140.61$8,436,600.003,692View SEC Filing  
4/10/2014Robert CosinukeCMOSell6,000$151.14$906,840.0044,804View SEC Filing  
4/2/2014Jonathan BushCEOSell1,000$161.74$161,740.00311,234View SEC Filing  
3/10/2014Robert CosinukeCMOSell6,000$181.60$1,089,600.0046,277View SEC Filing  
2/18/2014Timothy AdamsCFOSell30,000$194.58$5,837,400.0040,327View SEC Filing  
2/12/2014Dev IttycheriaDirectorSell2,000$181.17$362,340.008,574View SEC Filing  
2/10/2014Robert CosinukeCMOSell6,000$172.72$1,036,320.0053,321View SEC Filing  
2/3/2014Daniel OrensteinSVPSell1,000$146.73$146,730.0031,262View SEC Filing  
2/3/2014David Eric RobinsonDirectorSell4,000$146.86$587,440.002,058View SEC Filing  
1/10/2014Robert CosinukeCMOSell6,000$132.92$797,520.0053,321View SEC Filing  
1/3/2014David Eric RobinsonDirectorSell4,000$131.86$527,440.002,058View SEC Filing  
12/10/2013Robert CosinukeCMOSell6,000$132.77$796,620.0053,321View SEC Filing  
12/3/2013David Eric RobinsonDirectorSell4,000$132.48$529,920.002,058View SEC Filing  
12/2/2013Jonathan BushCEOSell1,000$132.24$132,240.00311,759View SEC Filing  
11/4/2013David Eric RobinsonDirectorSell4,000$137.26$549,040.00View SEC Filing  
11/4/2013Jonathan BushCEOSell1,000$137.26$137,260.00View SEC Filing  
11/1/2013Daniel H OrensteinSVPSell1,000$133.15$133,150.00View SEC Filing  
10/21/2013Timothy M AdamsCFOSell20,000$138.39$2,767,800.00View SEC Filing  
10/18/2013Ed ParkCOOSell10,021$123.36$1,236,190.56View SEC Filing  
10/18/2013Jonathan BushCEOSell20,000$120.00$2,400,000.00View SEC Filing  
10/10/2013Robert CosinukeCMOSell6,000$108.21$649,260.0053,321View SEC Filing  
10/3/2013David Eric RobinsonDirectorSell4,000$111.01$444,040.00View SEC Filing  
10/2/2013Jonathan BushCEOSell1,000$110.16$110,160.00View SEC Filing  
9/10/2013Robert CosinukeCMOSell6,000$109.68$658,080.00View SEC Filing  
9/3/2013Daniel OrensteinSVPSell1,000$106.73$106,730.0031,262View SEC Filing  
9/3/2013David Eric RobinsonDirectorSell4,000$106.53$426,120.002,058View SEC Filing  
9/3/2013Jonathan BushCEOSell22,105$106.45$2,353,077.25302,231View SEC Filing  
8/19/2013John KaneDirectorSell2,000$111.23$222,460.005,052View SEC Filing  
8/15/2013John KaneDirectorSell5,000$110.03$550,150.005,052View SEC Filing  
8/12/2013Robert CosinukeCMOSell6,000$115.72$694,320.0053,321View SEC Filing  
8/5/2013David Eric RobinsonDirectorSell4,000$114.01$456,040.00View SEC Filing  
8/1/2013Daniel H OrensteinSVPSell1,000$113.73$113,730.00View SEC Filing  
8/1/2013Jonathan BushCEOSell5,000$113.94$569,700.00302,231View SEC Filing  
7/12/2013Timothy M AdamsCFOSell10,000$106.14$1,061,400.00View SEC Filing  
7/11/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
7/10/2013Robert CosinukeCMOSell6,000$87.06$522,360.00View SEC Filing  
7/1/2013Daniel H OrensteinSVPSell1,000$85.01$85,010.00View SEC Filing  
7/1/2013Jonathan BushCEOSell5,000$85.39$426,950.00View SEC Filing  
6/17/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
6/10/2013Robert CosinukeCMOSell6,000$85.74$514,440.00View SEC Filing  
6/3/2013Daniel H OrensteinSVPSell1,000$84.22$84,220.00View SEC Filing  
6/3/2013Jonathan BushCEOSell5,000$84.39$421,950.00View SEC Filing  
5/10/2013Robert CosinukeCMOSell6,000$84.80$508,800.00View SEC Filing  
5/1/2013Jonathan BushCEOSell5,000$95.70$478,500.00View SEC Filing  
2/26/2013David Eric RobinsonDirectorSell10,000$90.13$901,300.00View SEC Filing  
8/10/2012Robert CosinukeCMOSell3,000$92.35$277,050.00View SEC Filing  
(Data available from 1/1/2013 forward)


athenahealth (NASDAQ ATHN) News Headlines

Brainstorm Health: Ingestible Gut Bacteria Monitor, Athenahealth Pressure, Open Offices and BiopharmaBrainstorm Health: Ingestible Gut Bacteria Monitor, Athenahealth Pressure, Open Offices and Biopharma - May 25 at 6:08 PM
Elliott Calls For Athenahealth To Commence Full Process Without Further DelayElliott Calls For Athenahealth To Commence Full Process Without Further Delay - May 24 at 5:53 PM
Elliott Pushes Athenahealth To Commence A Sale Process: Shareholders Have SpokenElliott Pushes Athenahealth To Commence A Sale Process: 'Shareholders Have Spoken' - May 24 at 3:18 PM
Austin 'key' to Athenahealth's growth as tech company hiresAustin 'key' to Athenahealth's growth as tech company hires - May 23 at 5:46 PM
Athenahealth could fetch $170/share - Deutsche BankAthenahealth could fetch $170/share - Deutsche Bank - May 22 at 5:16 PM
athenahealth (ATHN) PT Raised to $170.00 at Deutsche Bankathenahealth (ATHN) PT Raised to $170.00 at Deutsche Bank - May 22 at 12:30 PM
Austin key to Athenahealths growth as tech company hiresAustin 'key' to Athenahealth's growth as tech company hires - May 21 at 5:19 PM
athenahealth (ATHN) Receives Average Rating of "Hold" from Brokeragesathenahealth (ATHN) Receives Average Rating of "Hold" from Brokerages - May 21 at 11:35 AM
BRIEF-Janus Henderson Reports 11.9 Percent Stake In athenahealthBRIEF-Janus Henderson Reports 11.9 Percent Stake In athenahealth - May 19 at 8:02 AM
athenahealth (ATHN) Downgraded by ValuEngine to Holdathenahealth (ATHN) Downgraded by ValuEngine to Hold - May 18 at 11:48 PM
Today’s Free Research Report Coverage on Evolent Health and Three More Healthcare Information Services StocksToday’s Free Research Report Coverage on Evolent Health and Three More Healthcare Information Services Stocks - May 18 at 8:11 AM
athenahealth (ATHN) Insider Sells $165,385.80 in Stockathenahealth (ATHN) Insider Sells $165,385.80 in Stock - May 17 at 8:17 PM
athenahealth (ATHN) PT Raised to $160 at RBC Capitalathenahealth (ATHN) PT Raised to $160 at RBC Capital - May 17 at 7:13 PM
athenahealths (ATHN) Sector Perform Rating Reaffirmed at Royal Bank of Canadaathenahealth's (ATHN) Sector Perform Rating Reaffirmed at Royal Bank of Canada - May 17 at 5:53 PM
athenahealth (ATHN) PT Set at $160.00 by Jefferies Groupathenahealth (ATHN) PT Set at $160.00 by Jefferies Group - May 17 at 2:59 PM
athenahealth (ATHN) Expected to Post Quarterly Sales of $334.11 Millionathenahealth (ATHN) Expected to Post Quarterly Sales of $334.11 Million - May 17 at 2:20 AM
 Brokerages Anticipate athenahealth (ATHN) to Post $0.93 Earnings Per Share Brokerages Anticipate athenahealth (ATHN) to Post $0.93 Earnings Per Share - May 15 at 7:14 PM
athenahealth (ATHN) Lowered to "Hold" at Berenberg Bankathenahealth (ATHN) Lowered to "Hold" at Berenberg Bank - May 15 at 2:25 PM
Will athenahealth Be the Next Big Healthcare Deal?Will athenahealth Be the Next Big Healthcare Deal? - May 14 at 6:35 PM
Getting a Deal Done on athenahealth Might Be ToughGetting a Deal Done on athenahealth Might Be Tough - May 14 at 6:35 PM
BRIEF-Elliott Management Releases Letter To The Board Of AthenahealthBRIEF-Elliott Management Releases Letter To The Board Of Athenahealth - May 14 at 5:30 PM
Elliott Urges Athenahealth Board To Engage In Talks Regarding Its ProposalElliott Urges Athenahealth Board To Engage In Talks Regarding Its Proposal - May 14 at 5:30 PM
athenahealth (ATHN) Receives "Hold" Rating from Cantor Fitzgeraldathenahealth (ATHN) Receives "Hold" Rating from Cantor Fitzgerald - May 14 at 4:55 PM
Form 3 ATHENAHEALTH INC For: May 01 Filed by: Connor BretForm 3 ATHENAHEALTH INC For: May 01 Filed by: Connor Bret - May 12 at 8:10 AM
Who Else Could Buy athenahealth?Who Else Could Buy athenahealth? - May 10 at 8:07 AM
Investors Buy High Volume of athenahealth Call Options (ATHN)Investors Buy High Volume of athenahealth Call Options (ATHN) - May 10 at 2:40 AM
DIGITAL HEALTH BRIEFING: Athenahealth gets $7B bid — Teladoc taps mental health space for growth — US health ...DIGITAL HEALTH BRIEFING: Athenahealth gets $7B bid — Teladoc taps mental health space for growth — US health ... - May 9 at 5:49 PM
Why Athenahealth (ATHN) Is a Major Medtech Acquisition TargetWhy Athenahealth (ATHN) Is a Major Medtech Acquisition Target - May 9 at 8:05 AM
athenahealth (ATHN) Rating Increased to Buy at ValuEngineathenahealth (ATHN) Rating Increased to Buy at ValuEngine - May 8 at 11:54 PM
Insider Selling: athenahealth (ATHN) SVP Sells 422 Shares of StockInsider Selling: athenahealth (ATHN) SVP Sells 422 Shares of Stock - May 8 at 8:18 PM
athenahealth (ATHN) CEO Sells $3,875,000.00 in Stockathenahealth (ATHN) CEO Sells $3,875,000.00 in Stock - May 8 at 7:20 PM
athenahealth (ATHN) PT Raised to $160 at Baird Following Acquisition Offer by Elliot Managementathenahealth (ATHN) PT Raised to $160 at Baird Following Acquisition Offer by Elliot Management - May 8 at 5:54 PM
athenahealth (ATHN) PT Set at $150.00 by Leerink Swannathenahealth (ATHN) PT Set at $150.00 by Leerink Swann - May 8 at 3:45 PM
athenahealth (ATHN) PT Set at $130.00 by Jefferies Groupathenahealth (ATHN) PT Set at $130.00 by Jefferies Group - May 8 at 3:28 PM
athenahealth (ATHN) Stock Rating Upgraded by Evercore ISIathenahealth (ATHN) Stock Rating Upgraded by Evercore ISI - May 8 at 1:41 PM
Robert W. Baird Boosts athenahealth (ATHN) Price Target to $160.00Robert W. Baird Boosts athenahealth (ATHN) Price Target to $160.00 - May 8 at 11:02 AM
UPDATE: Evercore ISI Upgrades athenahealth (ATHN) to Outperform Following Takeover Bid from Elliot ManagementUPDATE: Evercore ISI Upgrades athenahealth (ATHN) to Outperform Following Takeover Bid from Elliot Management - May 8 at 8:04 AM
Heres what led up to Elliotts takeover bid for athenahealthHere's what led up to Elliott's takeover bid for athenahealth - May 8 at 8:04 AM
Elliott Management makes unsolicited bid for AthenahealthElliott Management makes unsolicited bid for Athenahealth - May 8 at 8:04 AM
[$$] Elliott Looks to Take Athenahealth Private[$$] Elliott Looks to Take Athenahealth Private - May 8 at 8:04 AM
Elliott bid for athenahealth buoys medical IT playersElliott bid for athenahealth buoys medical IT players - May 7 at 5:49 PM
Elliott Looks to Take Athenahealth PrivateElliott Looks to Take Athenahealth Private - May 7 at 5:49 PM
Elliott to make all-cash offer for Athenahealth, say sourcesElliott to make all-cash offer for Athenahealth, say sources - May 7 at 5:49 PM
Elliott bids for Athenahealth in all-cash offerElliott bids for Athenahealth in all-cash offer - May 7 at 5:49 PM
Heres Why Athenahealth Is Skyrocketing TodayHere's Why Athenahealth Is Skyrocketing Today - May 7 at 12:30 PM
athenahealth to Review Unsolicited Acquisition Proposal from Elliott Managementathenahealth to Review Unsolicited Acquisition Proposal from Elliott Management - May 7 at 10:52 AM
Elliott Management Makes $160-Per-Share Takeover Offer For AthenahealthElliott Management Makes $160-Per-Share Takeover Offer For Athenahealth - May 7 at 10:52 AM
Form 4 ATHENAHEALTH INC For: May 01 Filed by: Bush JonathanForm 4 ATHENAHEALTH INC For: May 01 Filed by: Bush Jonathan - May 2 at 8:09 AM
athenahealth (ATHN) PT Lowered to $155 at Piper Jaffray Following 1Q Conference Callathenahealth (ATHN) PT Lowered to $155 at Piper Jaffray Following 1Q Conference Call - May 2 at 8:09 AM
athenahealth (ATHN) CEO Jonathan Bush Sells 5,000 Sharesathenahealth (ATHN) CEO Jonathan Bush Sells 5,000 Shares - May 1 at 10:12 PM

SEC Filings

athenahealth (NASDAQ:ATHN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


athenahealth (NASDAQ:ATHN) Income Statement, Balance Sheet and Cash Flow Statement


athenahealth (NASDAQ ATHN) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.